FOUNDAYO 14.5 mg/1
orforglipron · TABLET, FILM COATED · Eli Lilly and Company
Foundayo (orforglipron) is an oral prescription tablet taken by mouth. The specific condition it treats and additional details about its use should be discussed with your healthcare provider or found on the medication's package insert.
Key Facts
- Brand Name
- FOUNDAYO
- Generic Name
- orforglipron
- NDC Code (Product)
0002-4839- Manufacturer
- Eli Lilly and Company
- Strength
- 14.5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA220934
- Marketing Start
- 04/01/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is FOUNDAYO used for?
Foundayo (orforglipron) is an oral prescription tablet taken by mouth. The specific condition it treats and additional details about its use should be discussed with your healthcare provider or found on the medication's package insert.
Is FOUNDAYO a controlled substance?
FOUNDAYO is not classified as a controlled substance by the DEA.
What is the generic name for FOUNDAYO?
The generic name for FOUNDAYO is orforglipron. There are no other listed brand versions of orforglipron.
What is the NDC code for FOUNDAYO 14.5 mg/1?
The NDC (National Drug Code) for FOUNDAYO 14.5 mg/1 is 0002-4839, listed by Eli Lilly and Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)